National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 366697

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 366697
VAERS Form:
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.


Changed on 9/14/2017

VAERS ID: 366697 Before After
VAERS Form:(blank) 1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 2 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.


Changed on 2/14/2018

VAERS ID: 366697 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.


Changed on 6/14/2018

VAERS ID: 366697 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.


Changed on 8/14/2018

VAERS ID: 366697 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.


Changed on 9/14/2018

VAERS ID: 366697 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.


Changed on 10/14/2018

VAERS ID: 366697 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.


Changed on 12/24/2020

VAERS ID: 366697 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.


Changed on 12/30/2020

VAERS ID: 366697 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.


Changed on 5/7/2021

VAERS ID: 366697 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.


Changed on 5/21/2021

VAERS ID: 366697 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:2009-09-11
Onset:2009-09-11
Submitted:2009-11-11
Entered:2009-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Nausea, Schizophrenia, Suicidal ideation, Vomiting, Mental disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601840A

Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=366697&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166